Re: [MSViews_Multiple_Sclerosis] Good News for Multiple Sclerosis Patients

[Guest guest]

I just can't understand this.........Two years ago this drug was called

" Antigren " and the trials were halted because the drug FAILED. Now two

years later the same drug has a new name and is approved and publicized.

BEWARE folks, something is " Fishy " here.

Regards,

Tom

[MSViews_Multiple_Sclerosis] Good News for Multiple Sclerosis

Patients

>

> Good News for Multiple Sclerosis Patients

>

> Dr. Ostrow's Recent Reports More >>

>

> http://www.wivb.com/global/story.asp?s=2633701

>

> Good News for Multiple Sclerosis Patients

>

> (November 30, 2004) - - The FDA has approved a new drug to help patients

> battling Multiple Sclerosis. In this medical report, Doctor Ostrow

> shows us how the drug, tested right here in Buffalo, is twice as good at

> stopping the debilitating effects of MS.

>

> Palloni's first MS attack was 12 years ago.

>

> Palloni: " I was trying to write something down and I couldn't write

> - it was only like scribbling - and my hand became numb. "

>

> An MRI scan showed the typical white spots of ms lesions. She was

> treated with the best drug available, Interferon, but still had

> occasionial relapses.

>

> Palloni: " I'd have weakness in my right leg, my right side, my arm. "

>

> An MS attack happens when inflammatory cells in the circulation leave

> the bloodstream and enter the brain.

>

> We can see that happening on an mri scan. Inside the ms plaque, those

> inflammatory cells attack the nerve fibers and their coverings, and

> that's what causes the symptoms. (shown on WIVB-TV)

>

> Frederick Munschauer, M.D., Chairman, Dept. of Neurology, University at

> Buffalo; Director, s Neurological Institute: " What we are trying to

> do with any therapy with MS is decrease the inflammation associated with

> the brain. "

>

> A new drug, Tysabri, does that very well. Inflammatory cells use surface

> proteins called integrins to leave blood vessels.

>

> Tysabri blocks those integrins so the cells can't reach the brain.

> Current treatments have been able to reduce attacks by 30 percent, but

> Tysabri reduced them by 67 percent.

>

> Dr. Munschauer: " It was so effective after one year that it led to the

> FDA approving the drug based on the first year alone, of a two year

> trial. Its become really a good time for patients with MS because

> there's hope - not a cure, but substantial hope that we can do better

> than we've ever done before. "

>

> Tysabri is infused for an hour once a month, and now that its available,

> MS patients will have the same reaction mary did.

> Palloni: " Very happy...very very happy. "

>

> She was one of many local patients who were involved in the trial.

>

> It is very uncommon that a drug is so effective that it gains FDA

> approval before the end of the clinical trial, but after one year, the

> advantage of Tysabri was very clear.

>

> Q. What will happen to Interferon?

> A. Interferon will still be used for some patients, and it may be

> that the combination of both treatments will be even more effective

> http://www.wivb.com/global/story.asp?s=2633701

>

>

>

>

> Link for chat:

> MSViews_Multiple_Sclerosis/chat

> Photos:

> http://photos./group/MSViews_Multiple_Sclerosis/lst

> Group Home: MSViews_Multiple_Sclerosis

> MyMSViews Home: http://www.mymsviews.org Home:

> MSViews_Multiple_Sclerosis

> MyMSViews Home: http://www.mymsviews.org

>